Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Comparing the efficacy and safety of safinamide with rasagiline in China Parkinson's disease patients with a matching adjusted indirect comparison

Tan Y, Wei Q, Xu P, Tao E, Wang L, Cattaneo C, Shang H, Chen S.

Sci Rep. 2025 Mar 26;15(1):10502. doi: 10.1038/s41598-025-94960-9.

Impact of Peripheral Inflammation on Blood-Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases

Beltran-Velasco AI, Clemente-Suárez VJ.

Int J Mol Sci. 2025 Mar 9;26(6):2440. doi: 10.3390/ijms26062440.

The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases

Zheng MY, Luo LZ.

Int J Mol Sci. 2025 Mar 11;26(6):2505. doi: 10.3390/ijms26062505.

Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases

Singh AA, Khan F, Song M.

Int J Mol Sci. 2025 Mar 17;26(6):2695. doi: 10.3390/ijms26062695.

ANXA2 Protein and Its Role in Neurodegeneration Processes

Partevian SA, Slominsky PA, Shadrina MI, Alieva AK.

Life (Basel). 2025 Mar 4;15(3):402. doi: 10.3390/life15030402.

Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss

Sundararaman L, Gouda D, Kumar A, Sundararaman S, Goudra B.

J Clin Med. 2025 Mar 14;14(6):1978. doi: 10.3390/jcm14061978.

Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting

Lei K, Zhou L, Dan M, Yang F, Jian T, Xin J, Yu Z, Wang Y.

Pharmaceutics. 2025 Feb 20;17(3):280. doi: 10.3390/pharmaceutics17030280.

Emerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment

Tew VK, Barathan M, Nordin F, Law JX, Ng MH.

Pharmaceutics. 2025 Feb 20;17(3):284. doi: 10.3390/pharmaceutics17030284.

Pharmaceutical 3D Printing Technology Integrating Nanomaterials and Nanodevices for Precision Neurological Therapies

Bernatoniene J, Plieskis M, Petrikonis K.

Pharmaceutics. 2025 Mar 9;17(3):352. doi: 10.3390/pharmaceutics17030352.

Targeting Neuroinflammation in Central Nervous System Diseases by Oral Delivery of Lipid Nanoparticles

Zou Y, Zhang J, Chen L, Xu Q, Yao S, Chen H.

Pharmaceutics. 2025 Mar 18;17(3):388. doi: 10.3390/pharmaceutics17030388.

Seaweed in the Diet as a Source of Bioactive Metabolites and a Potential Natural Immunity Booster: A Comprehensive Review

Mandal AK, Parida S, Behera AK, Adhikary SP, Lukatkin AA, Lukatkin AS, Jena M.

Pharmaceuticals (Basel). 2025 Mar 4;18(3):367. doi: 10.3390/ph18030367.

Systematic review of differentially abundant proteins in people with Lewy body dementia

Farr LM, Thorpe N, Brinda EM, Albalushi N, Sohail M, Rajkumar AP.

Acta Neuropsychiatr. 2025 Mar 27;37:e59. doi: 10.1017/neu.2025.15.

Preclinical insights into gamma-tACS: foundations for clinical translation in neurodegenerative diseases

Sánchez-Garrido Campos G, Zafra ÁM, Estévez-Rodríguez M, Cordones I, Ruffini G, Márquez-Ruiz J.

Front Neurosci. 2025 Mar 12;19:1549230. doi: 10.3389/fnins.2025.1549230. eCollection 2025.

Advances in autonomic dysfunction research in Parkinson's disease

Xu H, Zheng X, Xing X, Bi Z, Wang D, Zhang C, Wei L, Jin Y, Xu S.

Front Aging Neurosci. 2025 Mar 12;17:1468895. doi: 10.3389/fnagi.2025.1468895. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias